BSH 2019 | Carfilzomib and panobinostat for R/R multiple myeloma: Phase I results

Sagar Lonial

Sagar Lonial, MD, FACP, Emory University, Atlanta, GA, discusses the Phase I study of carfilzomib and panobinostat for the treatment of relapsed/refractory multiple myeloma. This interview took place at the British Society for Haematology (BSH) 2019 Annual Meeting, held in Glasgow, UK.

Share this video  
Similar topics